...
首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients
【24h】

Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients

机译:D-手性肌醇(DCI)对肥胖PCOS患者LH和胰岛素分泌的调节作用

获取原文
获取原文并翻译 | 示例
           

摘要

Polycystic ovary syndrome (PCOS) is a common endocrine condition that affects fertility through oligo-ovulation, hyperandrogenism and polycystic morphology of the ovaries. Since it has been demonstrated a high incidence of insulin resistance in PCOS patients, our study aimed to evaluate the efficacy of the integrative treatment with D-chiro-inositol (DCI) (500 mg die, per os, for 12 weeks) on hormonal parameters and insulin sensitivity in a group of overweight/obese PCOS patients (body mass index; BMI > 26). After the treatment, interval several endocrine parameters improved (luteinizing hormone [LH], LH/follicle stimulating hormone [FSH], androstenedione and insulin), insulin response to oral glucose tolerance test reported the significant improvement of insulin sensitivity as well as the gonadotropin-releasing hormone (GnRH)-induced (10 μg, in bolus) LH response. BMI decreased, though no lifestyle modification was requested. When data were analyzed according to the presence or absence of first-grade diabetic relatives, PCOS patients with diabetic relatives showed greater improvement after DCI administration. In conclusion DCI administration is effective in restoring better insulin sensitivity and an improved hormonal pattern in obese hyperinsulinemic PCOS patients, in particular, in hyperinsulinemic PCOS patients who have diabetic relatives.
机译:多囊卵巢综合征(PCOS)是一种常见的内分泌疾病,可通过排卵少,雄激素过多和卵巢多囊形态影响生育力。由于已证明PCOS患者中胰岛素抵抗的发生率很高,因此我们的研究旨在评估D-手性肌醇(DCI)(500 mg死,口服,持续12周)激素指标的综合治疗的疗效一组超重/肥胖PCOS患者的胰岛素和胰岛素敏感性(体重指数; BMI> 26)。治疗后,间隔内分泌参数有所改善(促黄体生成素[LH],LH /卵泡刺激素[FSH],雄烯二酮和胰岛素),口服葡萄糖耐量试验的胰岛素反应报告了胰岛素敏感性以及促性腺激素-显着改善。释放激素(GnRH)诱导的大剂量LH反应(剂量为10μg)。尽管没有要求改变生活方式,但BMI下降了。当根据一级糖尿病亲属的存在与否分析数据时,有DCI的PCOS糖尿病亲属患者表现出更大的改善。总之,在肥胖高胰岛素血症的PCOS患者中,尤其是在有糖尿病亲属的高胰岛素的PCOS患者中,DCI的给药可有效地恢复更好的胰岛素敏感性和改善的激素模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号